MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced that its Board of Directors’ Compensation Committee approved inducement grants of restricted stock units (RSUs) covering 4,000 shares of common stock. The grants, effective January 21, 2025, were awarded to seven newly hired employees as part of their compensation packages.
The RSUs were granted under Nasdaq Rule 5635(c)(4), which allows inducement grants for employees as an incentive to accept employment. The restricted stock units will vest in equal annual installments over four years, contingent on the employees’ continued service with TELA Bio through the specified vesting dates.
These grants exemplify TELA Bio’s effort to attract and retain top talent as the company continues to grow and innovate in the medical technology sector.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.